Cryopreservation of composite tissue transplants.
Composite tissue allotransplantation holds great promise for upper extremity reconstruction but is limited by donor part availability. Cryopreservation may increase the availability of donor parts and even reduce antigenicity. The purpose of the study was to evaluate the viability of cryopreserved composite tissues and to demonstrate the feasibility of microvascular isotransplantation of cryopreserved composite flaps. Twenty epigastric flaps were harvested from Lewis rats. Ten flaps were analyzed fresh. Ten flaps were perfused with dimethyl sulfoxide (DMSO)/trehelose cryoprotectant agent (CPA), frozen by controlled cooling to -140 degrees C, and stored for 2 weeks. Flaps were evaluated by factor VIII endothelial staining and MTT tetrazolium salt assay. For the in vivo phase, 30 flaps were harvested. Ten were transplanted fresh to isogenetic recipient animals, ten were perfused with CPA and transplanted, and ten were cryopreserved for 2 weeks, thawed, and transplanted. All cryopreserved samples displayed intact vascular endothelia on factor VIII staining. On MTT analysis, the epithelial viability index for the cryopreserved samples was not significantly different from fresh controls (p = 0.12). All freshly transplanted flaps (10/10) were viable at 60 days. Nine of ten flaps in the perfused/transplanted group were viable at 60 days. Survival of cryopreserved/transplanted flaps ranged from 5 to 60 days. The skin and vascular endothelial components of composite tissue flaps appear to retain their viability after cryopreservation. The in vivo studies demonstrate that the long-term survival of cryopreserved composite tissue transplants is feasible and support an indirect injury, rather than direct injury from freezing or cryoprotectant agents, as the mechanism of flap loss.
Rinker
Brian
B
Division of Plastic Surgery, University of Kentucky, Lexington, KY, USA. brink2@uky.edu
Cui
Xiangdong D
XD
Cibull
Michael L
ML
Fink
Betsy F
BF
Gao
Dayong Y
DY
Vasconez
Henry C
HC
Am J Transplant. 2006 Jan;6(1):20-6
16433752
Lancet. 1999 Apr 17;353(9161):1315-20
10218530
Am J Surg. 1998 Nov;176(5):418-21
9874425
Burns. 2003 Dec;29(8):759-67
14636749
Plast Reconstr Surg. 1993 Mar;91(3):492-501
7679796
Ann Plast Surg. 2002 Oct;49(4):404-9
12370647
N Engl J Med. 2000 Aug 17;343(7):468-73
10950668
J Reconstr Microsurg. 1998 Nov;14(8):559-64
9853947
J Pediatr Surg. 2003 Dec;38(12):1707-11
14666448
Lancet. 2006 Jul 15;368(9531):203-9
16844489
Microsurgery. 2000;20(8):360-71
11150985
Transplantation. 2003 Dec 27;76(12):1763-70
14688529
N Engl J Med. 2001 May 31;344(22):1676-9
11386266
Brain Res. 1997 Feb 28;749(2):200-8
9138719
Ann Surg. 2003 Jan;237(1):19-25
12496526
Transplantation. 2005 Mar 15;79(5):558-67
15753845
Hum Reprod. 2003 Jun;18(6):1165-72
12773441
Clin Plast Surg. 2005 Oct;32(4):463-70, v
16139620
World J Surg. 1998 Aug;22(8):818-23
9673553
Cell Tissue Bank. 2002;3(1):3-10
15256893
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2628-32
8464868
J Reconstr Microsurg. 2003 May;19(4):249-56
12858248
Plast Reconstr Surg. 2001 Nov;108(6):1655-60
11711942
Gynecol Endocrinol. 2007 Feb;23(2):87-93
17454158
Transplantation. 2002 Nov 15;74(9):1211-7
12451256
Cell Transplant. 2006;15(10):911-9
17299996
Ann Plast Surg. 1995 Aug;35(2):184-90
7486742
Plast Reconstr Surg. 1984 Sep;74(3):410-3
6236468
Plast Reconstr Surg. 1998 Nov;102(6):2033-9
9811001
Lancet. 2003 Jun 28;361(9376):2173-6
12842369
J Hand Surg Am. 2002 Jul;27(4):565-80
12132078
Microsurgery. 2000;20(8):375-83
11150987
Transplant Proc. 2004 Jun;36(5):1561-3
15251385
World J Gastroenterol. 2004 Feb 15;10(4):555-9
14966916
Liver Transpl. 2007 Jan;13(1):38-45
17154395